The company has now raised $17M in total funding, including a seed round co-led by General Catalyst and GSV Ventures. The raise comes amid growing momentum for the application of AI in healthcare, fueled by regulatory shifts toward technology-enabled care delivery (e.g., CMS ACCESS model) and growing provider demand for clinical agents.

Amigo is transforming care delivery with the industry's first approach to training AI agents like doctors. The company partners with healthcare organizations to define their AI strategy and build custom agents that launch safely at scale in over 100 languages. Enterprise deployment is supported by native integrations into all major EHRs (Epic, Oracle Health, Athenahealth, and more) and full HIPAA, SOC 2 Type II, and GDPR compliance.